TY  - JOUR

T1  - Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model

JO  - Health Technology Assessment

UR  - http://dx.doi.org/10.3310/yapl9347

PY  - 2024/10/01

AU  - Harnan S

AU  - Kearns B

AU  - Scope A

AU  - Schmitt L

AU  - Jankovic D

AU  - Hamilton J

AU  - Srivastava T

AU  - Hill H

AU  - Ku CC

AU  - Ren S

AU  - Rothery C et al

ED  - 

DO  - DOI: 10.3310/yapl9347

PB  - National Institute for Health and Care Research

SP  - 1

EP  - 230

Y2  - 2024/12/22

ER  -